alendronate/vitamine d3 ab 70 mg - 2 800 ie tabl.
aurobindo sa-nv - natriumalendronaattrihydraat 91,36 mg - eq. alendroninezuur 70 mg; cholecalciferol 70 µg - tablet - 70 mg - 2800 iu - natriumalendronaattrihydraat 91.36 mg; cholecalciferol 70 µg - alendronic acid and colecalciferol
alendronate/vitamine d3 ab 70 mg - 5 600 ie tabl.
aurobindo sa-nv - natriumalendronaattrihydraat 91,36 mg - eq. alendroninezuur 70 mg; cholecalciferol 140 µg - tablet - 70 mg - 5600 iu - natriumalendronaattrihydraat 91.36 mg; cholecalciferol 140 µg - alendronic acid and colecalciferol
flutisacombo 25 µg/dosis - 50 µg/dosis dosisaerosol susp. spuitbus
eg sa-nv - salmeterolxinafoaat 36,32 µg/dosis - eq. salmeterol 25 µg/dosis; fluticasonpropionaat 50 µg/dosis - aërosol, suspensie - 25 µg/dose - 50 µg/dose - salmeterolxinafoaat 36.32 µg/dosis; fluticasonpropionaat 50 µg/dosis - salmeterol and fluticasone
flutisacombo 25 µg/dosis - 125 µg/dosis dosisaerosol susp. spuitbus
eg sa-nv - salmeterolxinafoaat 36,32 µg/dosis - eq. salmeterol 25 µg/dosis; fluticasonpropionaat 125 µg/dosis - aërosol, suspensie - 25 µg/dose - 125 µg/dose - salmeterolxinafoaat 36.32 µg/dosis; fluticasonpropionaat 125 µg/dosis - salmeterol and fluticasone
flutisacombo 25 µg/dosis - 250 µg/dosis dosisaerosol susp. spuitbus
eg sa-nv - salmeterolxinafoaat 36,32 µg/dosis - eq. salmeterol 25 µg/dosis; fluticasonpropionaat 250 µg/dosis - aërosol, suspensie - 25 µg/dose - 250 µg/dose - salmeterolxinafoaat 36.32 µg/dosis; fluticasonpropionaat 250 µg/dosis - salmeterol and fluticasone
seretide 25 µg/dosis - 50 µg/dosis dosisaerosol susp. multidos. cont.
glaxosmithkline pharmaceuticals sa-nv - salmeterolxinafoaat 36,3 µg/dosis - eq. salmeterol 25 µg/dosis; fluticasonpropionaat 50 µg/dosis - aërosol, suspensie - 25 µg/dose - 50 µg/dose - fluticasonpropionaat 50 µg/dosis; salmeterolxinafoaat 36.3 µg/dosis - salmeterol and fluticasone
seretide 25 µg/dosis - 125 µg/dosis dosisaerosol susp. multidos. cont.
glaxosmithkline pharmaceuticals sa-nv - salmeterolxinafoaat 36,3 µg/dosis - eq. salmeterol 25 µg/dosis; fluticasonpropionaat 125 µg/dosis - aërosol, suspensie - 25 µg/dose - 125 µg/dose - fluticasonpropionaat 125 µg/dosis; salmeterolxinafoaat 36.3 µg/dosis - salmeterol and fluticasone
seretide 25 µg/dosis - 250 µg/dosis dosisaerosol susp. multidos. cont.
glaxosmithkline pharmaceuticals sa-nv - salmeterolxinafoaat 36,3 µg/dosis - eq. salmeterol 25 µg/dosis; fluticasonpropionaat 250 µg/dosis - aërosol, suspensie - 25 µg/dose - 250 µg/dose - fluticasonpropionaat 250 µg/dosis; salmeterolxinafoaat 36.3 µg/dosis - salmeterol and fluticasone
serevent evohaler 25 µg/dosis dosisaerosol susp. spuitbus
glaxosmithkline pharmaceuticals sa-nv - salmeterolxinafoaat 36,3 µg/dosis - eq. salmeterol 25 µg/dosis - aërosol, suspensie - 25 µg/dose - salmeterolxinafoaat 36.3 µg/dosis - salmeterol
thevier 25 µg tabl.
aspen pharma trading ltd. - natriumlevothyroxinepentahydraat 27,8 µg - eq. levothyroxinenatrium 25 µg - tablet - 25 µg - natriumlevothyroxinepentahydraat 27.8 µg - levothyroxine sodium